Europe rejects FDA audits under MRA (mutual recognition agreement)
This article was originally published in Clinica
Europe is taking a stronger position regarding the terms of the mutual recognition agreement (MRA) with the US in medical devices. A recent meeting of European experts decided that audits undertaken so far by the FDA in Europe in the presence of EU conformity assessment bodies (CABs) do not count as part of the MRA confidence-building programme. The reason is that the FDA did not give companies sufficient notice of the audits.
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.